Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Aqua Bio Technology ASA ( (DE:3FZ) ) has provided an update.
Aqua Bio Technology ASA has announced the appointment of Kristian Flaten as the new CEO, effective August 1, 2025. This leadership change comes as the company prepares to enter a phase of new priorities and cost adjustments, which will be detailed later in 2025. Flaten brings over 25 years of experience in finance and business, having previously served as CFO at IDEX Biometrics ASA and Quantafuel ASA, among others. His appointment is expected to guide Aqua Bio Technology through its strategic transition, potentially impacting its market positioning and operational efficiency.
More about Aqua Bio Technology ASA
Aqua Bio Technology ASA (ABTEC) operates in the skincare and non-food industry, focusing on distribution to B2C, B2B, B2B2, and providing freight, customs clearance, and logistics services. The company also develops sustainable biotechnology for skincare products and is listed on Euronext Expand Oslo.
YTD Price Performance: -57.21%
Average Trading Volume: 1,075,285
Current Market Cap: NOK123.7M
For detailed information about 3FZ stock, go to TipRanks’ Stock Analysis page.